Ocular Therapeutix: Q4 Earnings Snapshot

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $15.5 million in its fourth quarter.

On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 24 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The biotechnology company posted revenue of $14.1 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $13.6 million.

For the year, the company reported a loss of $71 million, or 97 cents per share. Revenue was reported as $51.5 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up